| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1191/0961203303lu322oa Detection and clinical significance of Ba2+- and Sr2+-dependent antiprothrombin antibodies in patients with systemic lupus erythematosus and antiphospholipid syndromeDepartment of Medicine, Teikyo University School of Medicine, Tokyo, Japan
Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan, jmatsuda{at}med.teikyo-u.ac.jp
Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan We conducted this study to confirm whether or not Ca2+-dependent antiprothrombinantibody (aPT) in patientssera with systemic lupuserythematosusand=or primary antiphospholipidsyndromewould react to prothrombin=phosphatidylserinein the presenceof Sr2+, Mn2+ or Ba2+, or divalentmetal ions like Ca2+, utilizingELISA, and to analyze the clinical significance of these metal-dependentaPT. We found the presence of Ba2+- and Sr2+-dependent IgG, IgM and IgA-aPT in up to 65% of patients negative for Ca2+-dependent IgG-, IgM and IgA-aPT. Maximally 69% of them were complicated by antiphospholipidsyndrome-relatedsymptoms. These data suggest that the measurementof Ba2+- and Sr2+- along with Ca2+-dependentaPT may become a clinicallyuseful tool to correctly detect patients with antiphospholipid-related complications. However, further study is needed to clarify the clinicopathologicaldifferences among these aPTs in the future.
Key Words: antiphospholipid antibody antiprothrombin antibody lupus anticoagulant anticardiolipin antibody
|